Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps...

in allergic reactions. The efficacy of omalizumab may vary among patients. To identify responders to omalizumab, the level of several biomarkers can be...

control. Experimentally, a low dose of methotrexate or cyclosporin and omalizumab (a monoclonal anti-IgE antibody) has been used. Treatment of autoimmune...

includes the use of antihistamines, corticosteroids, monoclonal antibodies (omalizumab), and in some cases, immunosuppressive drugs. Despite ongoing research...

long term antihistamine therapy is indicated. Immunosuppressants such as omalizumab or cyclosporin may also be used. About 20% of people are affected at some...

phase I to IV clinical trials of omalizumab in various indications, concluded that a causal relationship between omalizumab therapy and malignancy is unlikely...

off-label therapy with cyclosporine A or montelukast or add-on therapy with omalizumab, which is an approved treatment option for CSU. Angioedema, excruciatingly...

avoid food allergies, azathioprine and antibodies, including mepolizumab, omalizumab, infliximab, and adalimumab. The word enteritis (/ˌɛntəˈraɪtɪs/) uses...

CU is rather limited in most cases. Treatment(s) with mixed success: omalizumab (anti-IgE therapy), danazol (synthetic androgen), propranolol (beta blocker)...

have dangerous reactions to these drugs Monoclonal antibodies, such as omalizumab Corticosteroids The prognosis of MCAS is uncertain. The condition was...

approaches to reducing autumn exacerbations, but while costly, seasonal omalizumab treatment from four to six weeks before school return may reduce autumn...

marboxil), for influenza A and B (both treatment and prevention). Xolair (omalizumab), for asthma, chronic idiopathic urticaria (CIU), and nasal polyps. Zelboraf...

cells and thereby help prevent acute rejection of kidney transplants. Omalizumab inhibits human immunoglobulin E (IgE) and is useful in treating moderate-to-severe...

have generally been used to treat peanut and environmental allergies. Omalizumab, an injectable asthma treatment drug sold under the brand name Xolair...

to OIT to reduce immune response. In 1 trial, the monoclonal antibody omalizumab was combined with high-dose milk oral immunotherapy and saw positive results...

as of December 2021. Subcutaneous injection of the anti-IgE antibody omalizumab is being studied as a method of preventing recurrence, but it is not yet...

International Nonproprietary Names of humanized antibodies end in -zumab, as in omalizumab (see Nomenclature of monoclonal antibodies). Humanized antibodies are...

Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, et al. (March 2017). "Omalizumab facilitates rapid oral desensitization for peanut allergy". The Journal...

Twinject) for use in the event of a serious reaction. Studies have found that omalizumab (Xolair) may be an effective and safe treatment for cold urticaria in...

Prevention of bone fractures in cancer patients 1,288 2012 −13% Xolair (omalizumab) Moderate-to-severe asthma not controlled by inhaled steroids Chronic...

has been shown to reduce viral load and pro-inflammatory IL-1β in mice. Omalizumab, which was developed for treatment of severe allergic asthma, has shown...

mycophenolate, and azathioprine. Newer targeted medications, including omalizumab and belimumab, have also been used. Urticarial vasculitis is featured...

treatment options with oral corticosteroids, biological treatments (e.g. omalizumab, mepolizumab) or allergen immunotherapy. Eczema Asthma Rhinitis Anaphylaxis...

"Clot-busting" drug to treat acute myocardial infarction. 2003: Xolair (omalizumab): Subcutaneous injection for moderate to severe persistent asthma. 2003:...

treated solar urticaria with Omalizumab (trade name Xolair) which is commonly used to treat Idiopathic Urticaria. Omalizumab is a recombinant humanized...

years have been used to treat AERD including dupilumab, mepolizumab, omalizumab, and benralizumab. Among treatment options, biologics have the highest...

biosimilar, in 2023. Products under development include biosimilars of omalizumab, denosumab, golimumab, aflibercept, vedolizumab, and pembrolizumab. In...

et al. (2008). "Conversion of cetuximab, panitumumab, trastuzumab and omalizumab into T-cell-engaging BiTE antibodies creates novel drug candidates of...

 275–292. Zirbes JM, Milla CE (June 2008). "Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis". Pediatric...

olvanil (INN) omacetaxine mepesuccinate (USAN) omadacycline (USAN, INN) omalizumab (INN) omapatrilat (INN) omecamtiv mecarbil (USAN, INN) omeprazole (INN)...